Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and 'MSP1 IND.19' (2017)
- Authors:
- Rocha, Mariana Vilela
- Françoso, Katia Sanches
- Lima, Luciana Chagas
- Camargo, Tarsila Mendes
- Machado, Ricardo L. D
- Costa, Fabio T. M - Universidade Estadual de Campinas (UNICAMP)
- Rénia, Laurent
- Nosten, Francois
- Russell, Bruce
- Rodrigues, Mauricio M - Universidade Federal de São Paulo (UNIFESP)
- Soares, Irene da Silva
- USP affiliated authors: SOARES, IRENE DA SILVA - FCF ; FRANÇOSO, KATIA SANCHES - FCF
- Unidade: FCF
- DOI: 10.1016/j.vaccine.2017.03.023
- Subjects: MALÁRIA; PLASMODIUM
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
- Licença: cc-by-nc-nd
-
ABNT
ROCHA, Mariana Vilela et al. Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and 'MSP1 IND.19'. Vaccine, v. 35, p. 2463-2472, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2017.03.023. Acesso em: 28 dez. 2025. -
APA
Rocha, M. V., Françoso, K. S., Lima, L. C., Camargo, T. M., Machado, R. L. D., Costa, F. T. M., et al. (2017). Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and 'MSP1 IND.19'. Vaccine, 35, 2463-2472. doi:10.1016/j.vaccine.2017.03.023 -
NLM
Rocha MV, Françoso KS, Lima LC, Camargo TM, Machado RLD, Costa FTM, Rénia L, Nosten F, Russell B, Rodrigues MM, Soares I da S. Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and 'MSP1 IND.19' [Internet]. Vaccine. 2017 ; 35 2463-2472.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1016/j.vaccine.2017.03.023 -
Vancouver
Rocha MV, Françoso KS, Lima LC, Camargo TM, Machado RLD, Costa FTM, Rénia L, Nosten F, Russell B, Rodrigues MM, Soares I da S. Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and 'MSP1 IND.19' [Internet]. Vaccine. 2017 ; 35 2463-2472.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1016/j.vaccine.2017.03.023 - Plasmodium vivax malaria vaccine: immunization with a novel chimeric recombinant protein generates high IgG antibody titers and IFN-γ-secreting cells in mice
- Plasmodium vivax malaria vaccine: immunization with a novel chimeric recombinant protein generates high IgG antibody titers and IFN-y-secreting cells in mice
- Immunogenicity of a multi-antigen formulation based on plasmodium vivax malaria vaccine candidates
- Invasion-inhibitory antibodies elicited by immunization with Plasmodium vivax apical membrane antigen-1 expressed in Pichia pastoris yeast
- Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge
- Comparação da imunogenicidade de duas proteínas recombinantes baseadas na proteína circumsporozoíta (CS) de Plasmodium vivax
- Immunogenicity of a malaria vaccine candidate based on allelic forms of the plasmodium vivax circumsporozoite antigen administered in mice using different adjuvant formulations
- Naturally acquired immune response against a chimeric protein representing two highly antigenic proteins of plasmodium vitax
- Interaction between apical membrane antigen 1 of Plasmodium vivax with human erythrocytes detected by flow cytometry
- Recombinant Plasmodium vivax AMA1: production and purification under GLP conditions and analysis of immunogenicity in mice
Informações sobre o DOI: 10.1016/j.vaccine.2017.03.023 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
